 limit heterogen hla class II contribut suscept arthriti posit associ patient rheumatoid arthriti RA hla class II epitop molecul possibl associ present minor patient antigen eighti patient classic definit RA control hla-dr DQ DP type dna-bas system sequence-specif oligonucleotid amplifi class II allel polymeras chain reaction expect associ rel risk rel risk individu allel age- race-match control signific associ RA group patient control novel associ DR DQ DP allel evid contrast previou studi third allel hypervari region DR beta chain similar amino acid sequenc mani molecul result correl suscept determin hla-link suscept case RA